Regulations.gov document
Letter from Boehringer Ingelheim to FDA
Other · FDA-2020-P-2247 · posted Jun 22, 2022
Key facts
| Document ID | FDA-2020-P-2247-0021 |
|---|---|
| Title | Letter from Boehringer Ingelheim to FDA |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2020-P-2247 |
| Posted | Jun 22, 2022 |
| Comment period opens | Jun 22, 2022 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: